TP53 and neoplasm: These results are in agreement with those recently reported by Ciccone et al. that show how the pharmacological inhibition of CA IX induces tumor cell death by activating the apoptotic pathway involving p53 and caspase-3, and reduces cell invasion, inducing the switch from the mesenchymal phenotype toward an epithelial one [38].